Revvity
The firm said that its overall revenues rose 2 percent year over year and 4 percent on an organic basis with a smaller increase in its life sciences revenues.
In Brief This Week: Revvity; Devyser; Mursla Bio; Baebies; Apis Assay Technologies
News items for the week of April 21, 2025.
Tecan Acquires ELISA Immunoassay Assets From Revvity's Cisbio Bioassays
The purchase includes the manufacturing process of four ELISA kits, two of which are in vitro diagnostic products for specialty diagnostics and disease monitoring.
Revvity Gains FDA Approval for Automated Latent TB Test
The firm said that it has received approval for a test that combines the Allsheng-developed Auto-Pure 2400 liquid handling platform with Revvity's T-SPOT.TB test.
In Brief This Week: Quest Diagnostics; Revvity; Enzo Biochem; 4baseCare; Circular Genomics
News items for the week of March 17, 2025.
Feb 20, 2025
Jan 31, 2025
Jan 10, 2025
FDA Clears Revvity Free Testosterone Assay
Jan 7, 2025
Revvity Enters Into $1.5B Credit Facility
Oct 15, 2024